Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

HB0279 - Prescription Drug Affordability Board - Upper Payment Limits

Health and Government Operations 2/2/2023 3:00:00 PM
As of: 5/10/2024 10:11:11 PM
Name Organization Position Testimony Committee
Delegate Cullison, Delegate Cullison FAV In Person - Oral Testimony
HGO
Phelps, Jr., Kenneth Maryland Episcopal Public Policy Network FAV Virtual - Oral Testimony
HB 0279 - Favorable.pdf
HGO
DeMarco, Vincent FAV In Person - Oral Testimony
Testimony on HB 279 Upper Payment Limits 2023.pdf
HGO
Gutman, James AARP Maryland FAV Virtual - Oral Testimony
HB 279 AARP testimony on PDAB Upper Payment Limits
HGO
Black, Ashley Public Justice Center FAV HB 279_PJC_Favorable_HGO.pdf HGO
(MD), State of Maryland UNF 6 - HB 279 - HGO - MDH - LOC.docx (1) (1).pdf HGO
Progressive Caucus, Lower Shore Lower Shore Progressive Caucus FAV _TESTIMONY .pdf HGO
Egan, Ashley UULM-MD FAV Testimony- HB 279 Prescription Drugs-Support-UULM- HGO
Clayborne, MD, MA Bioethics Adjunct Prof., UMD, Elizabeth FAV In Person - Oral Testimony
Sponsor Testimony HB0279 - PDAB.pdf
HGO
Dumais, Brige 1199SEIU UHE FAV In Person - Oral Testimony
SB202HB279 Prescription Drug Affordability Board U
HGO
Kemerer, Hannibal Office of Attorney General FAV ReHB 279 Revised Support HGO
Plante, Cecilia Maryland Legislative Coalition FAV HB0279 Prescription Drug Affordability Board.pdf HGO
York, Andrew Maryland Prescription Drug Affordability Board FAV In Person - Oral Testimony
HB279.PDAB_LetterofSupport.pdf
HGO
Testimony, All N/A Merged Testimony as of 1-31-2023 at 312 PM HGO
Celentano, Matthew League of Life and Health Insurers FAV In Person - Oral Testimony
HGO
Schwartz, Paul NARFE FAV No Testimony HGO
Schwartz, Paul NARFE FAV In Person - Oral Testimony
HGO
Click to return on the top page